"10.1371_journal.pone.0151587","plos one","2016-03-16T00:00:00Z","Alan T Clarke; Paul C D Johnson; Gillian C Hall; Ian Ford; Peter R Mills","Dept. of Gastroenterology, Queen Elizabeth University Hospital, Glasgow, United Kingdom; Robertson Centre for Biostatistics, University of Glasgow, Glasgow, United Kingdom; Grimsdyke House London, London, United Kingdom; Dept. of Gastroenterology, Gartnavel General Hospital, Glasgow, United Kingdom; Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, United Kingdom","Conceived and designed the experiments: AC PM IF. Analyzed the data: AC PJ GH IF PM. Wrote the paper: AC PJ GH IF PM.","The authors have read the journal's policy and have the following competing interests: Dr. Gillian Hall has received consultancy fees from the following in the last 3 years - MSD (past), Sanofi-Aventis (past), Pfizer (past), Kinesys systems (past), Turnkey Pharma consulting (ongoing), Dance inc. (ongoing), Pharmo (ongoing), Shire Development Inc. (ongoing), Trevi Pharma (ongoing). Prof. Ian Ford is a co-applicant on a grant from MSD to analyse the 20 year follow-up of the WOSCOPS trial. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2016","03","Alan T Clarke","ATC",5,TRUE,3,NA,5,5,TRUE,TRUE,FALSE,0,NA,FALSE
